Skip to main content
Premium Trial:

Request an Annual Quote

OncoDNA Signs Distribution Agreements in Turkey, Romania

NEW YORK (GenomeWeb) – Belgian molecular diagnostics firm OncoDNA said today that it has signed agreements with Gammaray Private Health Services and AMS 2000 Trading Impex to distribute OncoDNA's molecular profiling products in Turkey and Romania, respectively.

The agreements confirm the growing interest of OncoDNA's comprehensive molecular profiling solutions in Turkey and Romania, OncoDNA CEO Jean-Pol Detiffe said in a statement. "We anticipate a strong increase in the use of OncoDNA profiling products" in Europe, Detiffe added.

"Patients [will] benefit from the most suitable and effective treatment options available to them, while exposure to potentially ineffective therapies are reduced under the guidance of useful precision medicine reporting services such as OncoSHARE," Gammaray CEO Cengiz Gemici said in a statement.

OncoDNA's platform combines comprehensive testing of all clinically relevant cancer biomarkers (DNA, RNA, and protein profiles) from both solid and liquid biopsies with a proprietary cancer treatment knowledge database called OncoKDO.

The news comes after OncoDNA said earlier this month that the Spanish Society of Pathology and the Spanish Society of Medical Oncology have endorsed usage of the firm's genomic tools to identify cancers of unknown primary origin.

The Scan

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.

Study Reveals Potential Sex-Specific Role for Noncoding RNA in Depression

A long, noncoding RNA called FEDORA appears to be a sex-specific regulator of major depressive disorder, affecting more women, researchers report in Science Advances.

New mRNA Vaccines Offer Hope for Fighting Malaria

A George Washington University-led team has developed mRNA vaccines for malaria that appear to provide protection in mice, as they report in NPJ Vaccines.

Unique Germline Variants Found Among Black Prostate Cancer Patients

Through an exome sequencing study appearing in JCO Precision Oncology, researchers have found unique pathogenic or likely pathogenic variants within a cohort of Black prostate cancer patients.